Tamer MD - TransMedics Chief Officer
| TMDX Stock | USD 78.58 2.54 3.34% |
Insider
Tamer MD is Chief Officer of TransMedics Group
| Age | 55 |
| Address | 200 Minuteman Road, Andover, MA, United States, 01810 |
| Phone | 978 552 0900 |
| Web | https://www.transmedics.com |
TransMedics Management Efficiency
The company has return on total asset (ROA) of 0.0284 % which means that it generated a profit of $0.0284 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1941 %, meaning that it created $0.1941 on every $100 dollars invested by stockholders. TransMedics' management efficiency ratios could be used to measure how well TransMedics manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.04 in 2024. Return On Capital Employed is likely to drop to -0.05 in 2024. At this time, TransMedics' Total Assets are fairly stable compared to the past year. Net Tangible Assets is likely to rise to about 226.3 M in 2024, whereas Intangible Assets are likely to drop slightly above 1.9 M in 2024.Similar Executives
| Showing other executives | INSIDER Age | ||
| BA Chemistry | Orthofix Medical | 63 | |
| Moshe Mizrahy | InMode | 71 | |
| Derrick Sung | Pulmonx Corp | 51 | |
| Mark Quick | Orthofix Medical | N/A | |
| Mitchell Hill | Inari Medical | 65 | |
| Michael Favet | Neuropace | 54 | |
| Jared Oasheim | CVRx Inc | 40 | |
| Georgia Melenikiotou | Inspire Medical Systems | 61 | |
| Geoffrey Rose | Pulmonx Corp | 50 | |
| Christopher Smith | Tela Bio | 63 | |
| Thomas MD | Inari Medical | 51 | |
| Kevin Muir | Delcath Systems | N/A | |
| Jee HamlynHarris | Penumbra | N/A | |
| Robin Wagge | Delcath Systems | N/A | |
| Rebecca Kuhn | Neuropace | 63 | |
| Anthony Dias | Delcath Systems | 57 | |
| Arani MD | Penumbra | 62 | |
| Janet Byk | Inari Medical | N/A | |
| MS MBA | Delcath Systems | 61 | |
| Andre Marquette | Neuropace | N/A | |
| Lisa Paul | Pulmonx Corp | 60 | |
Management Performance
| Return On Equity | 0.19 | ||||
| Return On Asset | 0.0284 |
TransMedics Group Leadership Team
Elected by the shareholders, the TransMedics' board of directors comprises two types of representatives: TransMedics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of TransMedics. The board's role is to monitor TransMedics' management team and ensure that shareholders' interests are well served. TransMedics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, TransMedics' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Miriam Provost, Vice Affairs | ||
| Mark Anderson, Senior Development | ||
| Susan Goodman, Vice Resources | ||
| John Carey, VP Operations | ||
| Nick Corcoran, Senior Operations | ||
| Stephen Gordon, Treasurer CFO | ||
| Tamer MD, Chief Officer | ||
| Anil Ranganath, General VP | ||
| Waleed MD, President, Founder | ||
| Laura Damme, VP Affairs | ||
| Nicholas Corcoran, Senior Operations |
TransMedics Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is TransMedics a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.19 | ||||
| Return On Asset | 0.0284 | ||||
| Profit Margin | 0.08 % | ||||
| Operating Margin | 0.04 % | ||||
| Current Valuation | 2.74 B | ||||
| Shares Outstanding | 33.56 M | ||||
| Shares Owned By Insiders | 3.17 % | ||||
| Shares Owned By Institutions | 96.83 % | ||||
| Number Of Shares Shorted | 8.43 M | ||||
| Price To Book | 12.16 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for TransMedics Stock Analysis
When running TransMedics' price analysis, check to measure TransMedics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TransMedics is operating at the current time. Most of TransMedics' value examination focuses on studying past and present price action to predict the probability of TransMedics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TransMedics' price. Additionally, you may evaluate how the addition of TransMedics to your portfolios can decrease your overall portfolio volatility.